Texas A&M researchers have found that curcumin, when activated by light, can weaken antibiotic-resistant bacteria, restoring the effectiveness of conventional antibiotics.
Curcumin: A Surprising Ally Against Superbugs
In 2017, a woman admitted to a Nevada hospital with pneumonia died from multiple organ failure and sepsis. The cause? A strain of bacteria resistant to 26 different antibiotics. These antibiotic-resistant bacteria, known as superbugs, pose a serious and growing global health threat.
In the fight against these dangerous pathogens, researchers at Texas A&M have discovered a potential new tool—curcumin, the natural compound that gives turmeric its bright yellow color.
Their study found that when bacteria consume curcumin and are then exposed to light, harmful reactions occur within the microbes, ultimately killing them. This approach reduces the number of antibiotic-resistant strains and restores the effectiveness of conventional antibiotics.
The findings were published in Scientific Reports.
The Antibiotic Crisis and the Rise of Superbugs
Before antibiotics, infectious diseases were the leading cause of death and disability around the world. With the advent of these life-saving medications, the human lifespan has increased by 23 years on average. In the last several decades, while the discovery of novel antibiotics has plateaued, antibiotic-resistant bacteria have simultaneously become more common, ushering in the era of superbugs, such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococcus, and pneumonia, which are all extremely hard to treat. In fact, infectious diseases are projected to be the main causes of human mortality once again, claiming up to 10 million lives annually.
A New Strategy to Overcome Antibiotic Failure
"When bacteria start becoming resistant to conventional antibiotics, we have what we call an antibiotic catastrophe," said Dr. Vanderlei Bagnato, professor in the Department of Biomedical Engineering and senior author on the study. "To overcome this challenge, we need alternative ways to either kill the superbugs or find a novel way to modify natural processes within the bacteria so that antibiotics start to act again."
Bacteria display natural variation within a given population. This heterogeneity introduces variations in cell behaviors, including response to antibiotics, which can directly contribute to treatment resistance if some strains survive antimicrobial medication and continue replicating. Thus, the researchers wanted to curb bacterial heterogeneity to control bacterial resistance.
Harnessing Light to Kill Drug-Resistant Bacteria
Photodynamic inactivation, a technique that has shown promise in combating bacterial resistance, uses light and light-sensitive molecules, called photosensitizers, to produce reactive oxygen species that can kill microorganisms by disrupting their metabolic processes. In their experiments, the team used curcumin, which is also a natural food for bacteria. They tested this technique on strains of Staphylococcus aureus that are resistant to amoxicillin, erythromycin, and gentamicin.
A Game-Changer for Antibiotic Effectiveness
The researchers exposed the bacteria to many cycles of light exposure and then compared the minimum concentration of antibiotics needed to kill the bacteria after light exposure versus those that did not get light exposure.
"When we have a mixed population of bacteria where some are resistant, we can use photodynamic inactivation to narrow the bacterial distribution, leaving behind strains that are more or less similar in their response to antibiotics," said Bagnato. "It's much easier now to predict the precise antibiotic dose needed to remove the infection."
Expanding the Potential of Curcumin Therapy
The team noted that photodynamic inactivation using curcumin has tremendous potential as an adjuvant or additional therapy with antibiotics for diseases, like pneumonia, caused by antibiotic-resistant bacteria.
"Photodynamic inactivation offers a cost-effective treatment option, which is crucial for reducing medical expenses not only in developing countries but also in the United States," said Dr. Vladislav Yakovlev, professor in the Department of Biomedical Engineering and author on the study. "It also has potential applications in military medicine, where this technology could be used to treat battlefield wounds and prevent the development and spread of antimicrobial resistance, a significant concern in combat situations."
Reference: "Photodynamic inactivation and its effects on the heterogeneity of bacterial resistance" by Jennifer M. Soares, Vladislav V. Yakovlev, Kate C. Blanco and Vanderlei S. Bagnato, 16 November 2024, Scientific Reports.
DOI: 10.1038/s41598-024-79743-y
Contributors to the research include Dr. Jennifer Soares, who is the primary author on the paper, and Dr. Kate Blanco from the Institute of Physics of São Carlos, University of São Paulo, Brazil.
This research was financially supported by the São Paulo Research Foundation, the National Council for Scientific and Technological Development, the Cancer Prevention and Research Institute of Texas, the Governor's University Research Initiative, the Air Force Office of Scientific Research, and the National Institutes of Health.
News
Cancer’s Hidden Antioxidant Shield Helps It Escape the Immune System
Blocking an antioxidant protein that tumors use to suppress immune attacks improved cancer immunotherapy responses in mice. Cancer cells can release antioxidants that interfere with the immune cells trying to kill them. Researchers have [...]
Scientists Find a Berry Compound That Helps Muscle Cells Burn Fat
Pterostilbene, a compound found naturally in some foods, affects how skeletal muscles process fats by stabilizing a protein called PPARδ and increasing its signaling activity. Pterostilbene, a natural compound found in blueberries, grapes, and [...]
Two Hidden Forces Help Build the Human Brain Before Birth
Scientists have uncovered two surprising forces that help guide how the human brain forms before birth. Before birth, the human brain is shaped in large part by an unusual class of stem cells known [...]
Researchers Uncover a Hidden Trigger Behind Chronic Inflammation
The findings offer new insights that could help guide the development of future therapies. A protein called human resistin may help flip on one of the immune system’s most powerful inflammatory switches. Researchers at [...]
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
